Projects per year
Personal profile
Education
- 2014-2020 Ph.D., The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2000-2007 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- Attending Physician, Taipei Medical University Hospital
- 2021.01- Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2020.11- Assistant Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
- 2019.08-2020.12 Acting Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2014.04-2015.06 Adjunct Attending Physician, Taipei Medical University Hospital
- 2013.04-2014.09 Adjunct Attending Physician, Landseed International Hospital
- 2012.11-2015.06 Attending Physician, Taipei Municipal Wanfang Hospital
Fingerprint
Dive into the research topics where Hsin-Lun Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Investigating the Dynamic Change of Genotype and Phenotype in Circulating Tumor Cells and Its Clinical Significance in Cancer Progression
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
Stem Cell-Based Approaches and Organotypic Culture System for Dissecting Pathogenic Mechanisms and Establishing Therapeutic Strategies for Inflammatory Bowel Diseases and Gastrointestinal Cancer(3/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
利用幹細胞及類器官技術剖析發炎性腸道疾病及消化道癌症的病理機轉並發展治療策略(2/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
利用幹細胞及類器官技術剖析發炎性腸道疾病及消化道癌症的病理機轉並發展治療策略(1/3)
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers
Kanno, Y., Chen, C. Y., Lee, H. L., Chiou, J. F. & Chen, Y. J., May 7 2021, In: Frontiers in Oncology. 11, 640392.Research output: Contribution to journal › Review article › peer-review
Open Access2 Citations (Scopus) -
Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy
Lo, C. H., Lee, H. L., Hsiang, C. W., Chiou, J. F., Lee, M. S., Chen, S. W., Shen, P. C., Lin, C. S., Chang, W. C., Yang, J. F., Dai, Y. H., Chen, C. Y., Chia-Hsien Cheng, J. & Huang, W. Y., Feb 1 2021, In: International Journal of Radiation Oncology Biology Physics. 109, 2, p. 474-484 11 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Real-time magnetic resonance guided focused ultrasound for painful bone metastases
Wang, W. J., Lee, H. L., Jeng, S. C., Chiou, J. F. & Huang, Y., Mar 2021, In: Journal of Visualized Experiments. 2021, 169, e60615.Research output: Contribution to journal › Article › peer-review
-
A combined systemic strategy for overcoming cisplatin resistance in head and neck cancer: From target identification to drug discovery
Chen, Y. J., You, G. R., Lai, M. Y., Lu, L. S., Chen, C. Y., Ting, L. L., Lee, H. L., Kanno, Y., Chiou, J. F. & Cheng, A. J., Nov 2020, In: Cancers. 12, 11, p. 1-20 20 p., 3482.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer
Lee, H. L., Chiou, J. F., Wang, P. Y., Lu, L. S., Shen, C. N., Hsu, H. L., Burnouf, T., Ting, L. L., Chou, P. C., Chung, C. L., Lee, K. L., Shiah, H. S., Liu, Y. L. & Chen, Y. J., Nov 2020, In: Cancers. 12, 11, p. 1-17 17 p., 3394.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Datasets
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606626/1
Dataset
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606698/1
Dataset
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://figshare.com/collections/Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/3931717/1
Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM2_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606662/1
Dataset